Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Home
Research Units
Experts
Publications
Projects
Datasets
Prizes
Spin-Offs
Activities
Media
Search by expertise, name or affiliation
Myeloablative radioimmunotherapy in conditioning prior to haematological stem cell transplantation: Closing the gap between benefit and toxicity?
Inga Buchmann
*
, Ralf G. Meyer, Walter Mier, Uwe Haberkorn
*
Corresponding author for this work
Clinic of Radiology and Nuclear Medicine
Johannes Gutenberg University Mainz
Ruprecht-Karls Universität Heidelberg
10
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Myeloablative radioimmunotherapy in conditioning prior to haematological stem cell transplantation: Closing the gap between benefit and toxicity?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Antileukemic Agent
20%
Combination Therapy
20%
Comorbidity
20%
Conditioning
100%
Drug Megadose
40%
Individualization
20%
Monoclonal Antibody
40%
Myeloablative Conditioning
20%
Pentetic Acid
40%
Radioactive Tracer
20%
Radioimmunotherapy
100%
Reduced Intensity Conditioning
20%
Yttrium 90
20%
Pharmacology, Toxicology and Pharmaceutical Science
Antileukemic Agent
50%
Combination Therapy
50%
Comorbidity
50%
Monoclonal Antibody
100%
Tracer
50%
Yttrium 90
50%
Immunology and Microbiology
Autologous Hematopoietic Stem Cell Transplantation
33%
Comorbidity
33%
Drug Megadose
66%
Monoclonal Antibody
66%